Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Adriamycin therapy on cardiac strain parameters in breast cancer
IRCT2014060112924N2Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2012
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of doxorubicin in breast cancer, sponsored by Mashhad University of Medical Sciences. Primary endpoints: Change in myocardial strain parameters and Change in myocardial strain rate parameters. Started Apr 2012; status: completed.
02
Drugs
doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT2014060112924N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014060112924N2.